Journal of Advances in Biology & Biotechnology

Ulcerative colitis (UC) is one of the two major types of inflammatory bowel disease (IBD), along with Crohn disease (CD). Unlike Crohn disease, which can affect any part of the gastrointestinal tract, UC characteristically involves the large bowel. One to two million Americans and many more people worldwide suffer from ulcerative colitis (UC), a subtype of inflammatory bowel disease. Although the precise origin of ulcerative colitis is still unknown, a mix of environmental and genetic factors seems to be involved. Conventional therapies can be useful in preserving remission and shortening the duration of active disease phases, but they have drawbacks, and many UC patients do not react to even the most potent medications. This article examines possible non-traditional therapies, such as transdermal nicotine, probiotics, fiber, dietary modifications, and other nutrients, that could be used in addition to traditional methods or as part of an all-encompassing alternative therapy regimen. This review also discusses the disease's extra-intestinal manifestations, conventional treatment methods, nutritional deficits, risk factors, and pathophysiology. Although ulcerative colitis is a serious condition, it is treatable. People can reduce difficulties and lead normal, active lives with early diagnosis and appropriate treatment. Transdermal nicotine, melatonin, DHEA, probiotics, omega-3s, dietary modifications, specific fibers, flavonoids, and anti-inflammatory botanicals show promise as adjuncts to conventional therapy or as part of a holistic approach to UC.